NTT DATA: Vaccine Distribution, Taking a Starbucks Approach
President Joe Biden and his advisers have inherited, or rather, not inherited, a . However, President Biden has committed to turning around the pandemic and picking up the pace on vaccinating Americans. The question is, how?
Thompson's vast experience in the "back-end" of the supply chain and working with Fortune 100 companies has prepared her well for this moment – the most crucial and critical moment for every link in the vaccine supply chain to work harmoniously in saving lives.
Frankly stated, Sylvie Thompson knows what she's talking about when it comes to supply chain, and she believes the White House should follow a Starbucks, rather than a stadium or mega-site like approach.
To ensure optimal execution, minimise wastage and mitigate risks, we must take a more holistic approach. The needs of our most vulnerable and the complexities that lay within the supply chain must be carefully considered and planned for. If ignored, these complexities will lead to increased waste, lowered efficiencies, and deleterious outcomes.
Sylvie thinks that we need vaccination locations on every other corner in order set-up a defined number of appointments, establish daily delivery routes, track vaccines by dose, and ensure follow-up procedures for second doses are completed including receiving the second dose from the same manufacturer.
The current operation of mega vaccination sites create mega-confusion and can disrupt the flow of resources.
"There are immense logistical differences between managing a small local corner store v.s a mega stadium. And from a supply chain perspective, I think if you understand the workings behind the scene, you come to the belief that although it may make for a good storyline and great PR to say, 'Dodgers Stadium is open, and 20,000 people are going to get vaccinated every day.' because it makes people feel like you're doing something, in the end, the question should be, are you achieving anything? And in actuality, you may just be complicating the supply chain even more," said Thompson.
She continues, "We have constrained supply, a core group of high-risk people we need to not only prioritise in terms of putting them at the front of the line but ensuring a safe environment and systematic process with limited barriers so as to not impede them from getting the vaccine. We also have healthcare workers who we need to rely on to perform the vaccines that also must be vaccinated. "
"We must remember, we have spent months telling people to stay away from large crowds, to stay home, and not hug their grandchildren or loved ones. And now we're saying, 'Get in line. Stand in line with 10,000 other people for hours and hours at a mega-site.' So I think, one, that the inconsistency in communication is a fundamental issue, but also, from a supply chain perspective, it creates way too many variables."
West Virginia's Vaccine Distribution Plan, "Save our Wisdom"
West Virginia stands as a prime example of how a "Starbucks like" approach, as Sylvie calls it, could increase the efficacy of the rollout.
West Virginia has successfully administered the vaccine to roughly 9 per cent of West Virginians, more than every other state other than Alaska, and double the number of some. Crucially, they also currently lead in the number of second doses that have been given.
Dr Paul Offit, director of the Vaccine Education Center and professor of paediatrics at Children's Hospital of Philadelphia of the two-dose vaccine could eventually drive the virus to mutate away from the vaccine and render it less effective.
When it came to the vaccine distribution plan, West Virginia officials decided to take matters into their own hands. Rather than follow the federal plan that partnered with Walgreens and CVS, they set their own strategy, focused on distributing through local independently owned pharmacies and about 200 long-term care facilities.
"Why? Right now, you have a group of people who are fearful of leaving their house. They're fearful of going into crowds, and they're also fearful about getting vaccinated." Thompson says.
"So you have to get them into a small group where they feel they can ask their questions, it's somebody they trust, and they don't have to go far from home. And by doing that in small clusters, you can also follow up with them and make sure they get the second vaccine dosage by the same manufacturer. And I think sometimes we forget that complexity."
"Let's be clear; I'm not against mega sites in their entirety. I just think that at this junction, they're probably not the optimal path. Later, when you are dealing with healthy people, when you start vaccinating people in their 30s, 40s and 50s maybe, then it may work. But at this point in time, you're dealing with a group of high-risk people and a limited supply."
The Supply Chain Complexities of Vaccine Distribution
"The other thing if you look at it purely from a supply chain perspective, it's somewhat counterintuitive, setting up last-mile delivery, for example. The hardest thing in last-mile delivery is your routes and understanding the volume that you have to give. And when the shipments change every day, the human brain just isn't capable of making the necessary calculations. You have to have software technology. But if you can set up a static route, like your postman for example; he's just got his route, and it's easy to calculate exactly how many to drop off to him every day, and it becomes extremely efficient."
What Sylvie is describing is what is known as a pull system. The most easily recognisable of which is the cans on the grocery store shelf. Once only a certain number of cans remain a card signals the need to restock. The main differentiator between a pull system and push, its counterpart, is that instead of the supply chain pushing inventory up based on assumptions of what is needed, you draw, based on actual usage.
"I know I have 1200 locations in the state of Virginia. Each one of them needs 100 every day. I have a defined schedule. It's easy math. That same information then feeds requirements downwards to inform all other requirements. The fulfilment centre filling those trucks each day knows how many they need to ship and where. You can peel it back to know exactly how much you need to pull from stockpiles, from manufacturers." Sylvie explains.
"The problem with mega-sites is they introduce too much variability. Am I going to get 10,000 people today or 20,000 people? Am I going to run out at 9,000 and send 7,000 people home?" As those in supply chain well know, variability is a nemesis, compounds complexities and increases the likelihood of disruptions.
Of course, with increased volume comes less control and increased waste, whether from damage or loss. "You're going to have stuff that's accidentally going to sit out, not through anybody's intentional behaviour. It's just the sheer size of the site is going to force you to end up with higher waste than what you would have if you were managing it in a smaller, more controlled setting."
"Unfortunately, whether we like it or not, we can't just open the flood gates, so we do need to pick. When you have supply constraints, you have to pick those groups of most vulnerable people who need it the most. Going to the small sites gives you that, which is why I say, I think when there's no supply constraints and six months from now when everybody's feeling much more comfortable, can you go to mega-sites? Yes. But is that really the answer right now?"
An added piece to an already complex puzzle is the need to phase in capacity to allow the room to administer second doses. "So if I only have 1000 appointments, and I max out 1000 on day one, on day 22, my 1000 appointments are already taken because of all the people from day one. So then I'll spend X number of days not vaccinating anybody new if I don't add more capacity. So there's this whole planning cycle that has to take place. We have to ramp this up in a way that we're constantly vaccinating new people but allocate the capacity to give that second dose and are holding that inventory for them."
Add to this the fact that Pfizer and Moderna require different interval windows (21 days for the Pfizer vaccine or 28 days for the Moderna vaccine), experts can't seem to agree on , and the has already reminded us about the importance of receiving the vaccine according to how the FDA has authorised them.
A methodical, people-minded and safety-focused 'Starbucks-like' approach may not make for splashy headlines, but in the end, it could save lives, and get us further, faster in this fight to find our way back to a new 'normal'.
Sylvie is Canadian, born, raised, and educated and now lives in northern Virginia. She started her career at the 'front-end' of supply chain in aerospace and defence procurement and is passionate about Supply Chain.
NTT DATA Services. is a leading global technology services company that works with organisations worldwide to achieve their desired business outcomes by leveraging intelligent, data-driven and securely connected technology solutions. For more on NTT DATA, click .